{
  "name" : "dacemirror.sci-hub.se_journal-article_8ae597cf60cc0594cac0bad281d6202b_deloid2017.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials",
    "authors" : [ ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : null,
      "text" : "© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\nnature protocols | VOL.12 NO.2 | 2017 | 355"
    }, {
      "heading" : "IntroDuctIon",
      "text" : "The unique physicochemical properties of ENMs are being exploited for use in a growing variety of commercial nano-enabled products (NEPs), including electronics, cosmetics, and structural materials, as well as a wide variety of products for antimicrobial, agricultural, medical, therapeutic, and diagnostic applications1–8. The rapid proliferation and commercialization of these ENMs and associated NEPs poses a potential risk of both occupational and consumer exposures to materials for which toxicological data are extremely limited9–17. Moreover, the high degree of variability in physicochemical properties such as composition, size, morphology, surface topology, chemistry and modifications, crystallinity, and impurity content among these ENMs presents a substantial challenge to the nanotoxicology field18–22. In addition, human exposure is not limited to pristine ENMs but also includes a wide variety of particles released from NEPs across their life cycle, including at the consumer use and disposal stages6,23,24. Indeed, the potential for exposure from such life cycle particulate matter (LCPM) may exceed that of pristine ENMs23. To complicate the matter further, the physicochemical properties and toxicological profiles of LCPM may differ greatly from those of the corresponding pristine ENMs14,25–31.\nTo address the vast and growing number and variety of ENMs entering the market, there is great need for fast, inexpensive, and in vivo-validated high-throughput screening strategies based on in vitro cellular assays. However, in vitro testing results from different labs often contradict one another, and even greater disparity is observed between in vitro and in vivo results19,20,32. Much of this in vitro vs. in vivo disparity can be explained by the failure of simple cellular systems (which often use immortal, i.e., highly abnormal, cell lines) to adequately recapitulate the complex milieu of a mammalian organism. However, it is likely that mismatch of in vitro and in vivo doses, due to inadequate ENM characterization—and particularly failure to adequately account for fate and transport of ENMs in vitro—is a major contributor to these disparities33–38."
    }, {
      "heading" : "Assessment of ENM fate and transport",
      "text" : "In a typical in vitro cellular assay, ENMs are dispersed in cell culture media, and the resulting suspension is dispensed onto\nadherent cells in multiwell cell culture plates. Cellular responses are measured following incubation (typically 24 h) over a range of doses to establish a dose–response relationship. The doses most often used to define these relationships are measured as total administered mass, surface area or number of particles, or the per volume concentration of mass, surface area, or particles in the initial administered suspension. This in vitro hazard and bioactivity assessment approach has been widely and successfully used for industrial and environmental chemicals, as well as for drug candidates39,40. However, because ENMs in suspension are subject to ENM- and media-specific physicochemical transformations that affect their fate and transport, and thus the dose delivered to cells is a function of exposure time33,36,37,41,42, it is not suitable for assessment of colloidal suspensions of ENMs.\nWhen ENMs are suspended in cell culture media or physiological fluids, they may form agglomerates consisting of multiple protein-coated primary particles and trapped intra-agglomerate fluid. The extent and kinetics of protein corona and agglomerate formation, and the size distribution and stability of agglomerates, are largely determined by the intrinsic properties of the primary ENM particles (i.e., composition, size, shape, surface chemistry) and the extrinsic properties of the fluid (i.e., ionic strength, pH, protein and other biomolecular types, and content)42,43. The degree of agglomeration and the stability of the resulting size distributions are also highly dependent on the methods used to disperse the ENMs in the liquid33. These transformations have critically important effects on nano-biointeractions between suspended ENMs and cells. Agglomeration reduces the total number of particles, as well as the total surface area of the suspended ENM available for interaction with cells. Indeed, cellular toxicity studies have demonstrated that agglomerated nanoparticles exert substantially different biological effects as compared with those exerted by well-dispersed nanoparticles of the same material44,45.\nAgglomeration also determines the key properties that determine the fate and transport of particles in suspension, namely size and effective density36,37. The agglomeration state of suspended ENMs can range from no agglomeration at all, with suspended\nPreparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials"
    }, {
      "heading" : "Glen M DeLoid, Joel M Cohen, Georgios Pyrgiotakis & Philip Demokritou",
      "text" : "Center for Nanotechnology and Nanotoxicology, HSPH-NIEHS Nanosafety Research Center, Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, USA. Correspondence should be addressed to P.D. (pdemokri@hsph.harvard.edu).\nPublished online 19 January 2017; doi:10.1038/nprot.2016.172\nevidence continues to grow of the importance of in vitro and in vivo dosimetry in the hazard assessment and ranking of engineered nanomaterials (enMs). accurate dose metrics are particularly important for in vitro cellular screening to assess the potential health risks or bioactivity of enMs. to ensure meaningful and reproducible quantification of in vitro dose, with consistent measurement and reporting between laboratories, it is necessary to adopt standardized and integrated methodologies for (i) generation of stable enM suspensions in cell culture media; (ii) colloidal characterization of suspended enMs, particularly of properties that determine particle kinetics in an in vitro system (size distribution and formed agglomerate effective density); and (iii) robust numerical fate and transport modeling for accurate determination of the enM dose delivered to cells over the course of the in vitro exposure. Here we present an integrated comprehensive protocol based on such a methodology for in vitro dosimetry, including detailed standardized procedures for each of these three critical aims. the entire protocol requires ~6–12 h to complete.\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\n356 | VOL.12 NO.2 | 2017 | nature protocols\nforms having diameters on the same order as the primary particles, to formation of large micron-sized agglomerates containing hundreds or thousands of primary particles. Because the sedimentation rate of a particle in suspension is proportional to the square of its diameter, a tenfold difference in size results in a 100-fold difference in sedimentation rate, and roughly the same fold difference in delivered in vitro dose37. The other key determinant of transport is effective density. Because agglomerates can contain relatively large amounts of medium, the effective density of suspended ENMs can be much less than the density of the primary particle material, and it is often closer to the density of the medium36. Because the sedimentation rate is directly proportional to the difference between the medium and the agglomerate effective density, this can also have a large effect on the dose delivered to cells over time. It was recently demonstrated that buoyant ENMs present a special case and challenge for characterization and dosimetric analysis46. If the raw material density is lower than the medium density, as in the case of some conjugated polymers, nanobubbles and liposomes used in nanomedicine and food applications47–50, the agglomerates do not settle, but instead rise or float away from cells over time, making the dose–response relationship impossible to determine. We have recently demonstrated that, in a standard cell culture system, buoyant polypropylene ENMs have no effect on cells, whereas in an inverted cell culture system, in which cells are oriented above the ENM suspension, the same ENMs produced dose-dependent increases in cytotoxicity and reactive oxygen species generation46.\nDosimetry can affect interpretation of in vitro hazard ranking results. In vitro nanotoxicology is comparative in nature, often relying on previously studied nanomaterials as controls to provide hazard rankings among large panels of ENMs. However, studies often fail to sufficiently characterize colloidal properties of suspended materials or to account for effects of these properties on fate and transport and the exposure dose delivered to cells. The critical role of dosimetry in interpretation of in vitro nanotoxicology studies was highlighted in the seminal work of Wittmaack, who reported the formation and rapid settling and accumulation of micron-sized agglomerates of suspended nanostructured powders51. Importantly, Wittmaack pointed out that the resulting exceedingly high exposure doses could cause physical overload effects from overlying or internalized ENMs that could be misinterpreted as toxicity. Additional studies by Wittmaack reported that in vitro toxicity of SiO2 nanoparticles was dependent upon the areal density of nanoparticle mass delivered to cells over the exposure duration, further emphasizing the importance of particle kinetics in interpretation of biological responses52. Thus, an ENM that forms large and dense—and thus rapidly sedimenting—agglomerates that quickly concentrate around cells may be reported as more toxic than one that forms smaller and less dense—and thus slower-settling—agglomerates, even though the latter material might well be more toxic than the former at equivalent delivered doses53. Recent studies report the impact of agglomerate properties on the time required for ENM delivery to cells in vitro37,54, and demonstrate the subsequent impacts of dosimetry on hazard ranking of large panels of low-aspect-ratio ENMs53.\nMoreover, cell uptake and translocation in vitro is strongly dependent on ENM characteristics and composition, protein content of the medium, and the dose delivered to cells55,56.\nThus, methods for reproducibly generating ENM suspensions, and accurate ENM- and media-specific characterization and dosimetry in vitro, are essential for predicting uptake and translocation biokinetics and biological effects in vitro. More importantly, doses used for in vitro testing should be matched with in vivo exposure doses, which in turn should be based on realistic potential human exposures34,35,39. Until recently, this was rarely done, in part because the tools necessary to correctly match in vivo and in vitro exposures have not been available. However, with accurate in vitro and in vivo computational dosimetry modeling now available, it is possible to bring in vitro cellular and in vivo animal exposures into alignment. For example, delivered doses for in vivo particle inhalation exposures can be quantified using the multiple-path particle dosimetry model (MPPD)57. The MPPD provides, for a given human or animal model (lung/ airway anatomy and geometry, breathing parameters), ENM aerosol characteristics, and exposure time, an estimate of the ENM mass deposited per unit area of the lung, and is the gold standard for dosimetry in animal studies of ENM inhalation exposures34,58,59. The in vivo-deposited mass per unit lung area obtained from a MPPD can then be used as a target deposited mass per area for in vitro experiments, and the corresponding initial administered in vitro ENM concentrations needed to obtain that target delivered dose can be determined using computational modeling approaches such as the volumetric centrifugation method– in vitro sedimentation, diffusion and dosimetry (VCM–ISDD) or distorted grid (DG) model14,37,54,60.\nThus, in addition to errors in hazard ranking, the failure to adequately account for fate and transport probably contributes to the inconsistent results within and especially between laboratories, to skewed relationships between toxicological outcomes and physicochemical properties, and to conflicting findings between in vitro and in vivo experiments. For these reasons, development of an integrated, validated dosimetry methodology has become a high priority in in vitro nanotoxicology.\nRecently, integrated, hybrid in vitro dosimetric platforms have been developed to address this important issue. Such integrated platforms include the preparation and proper characterization of ENM suspensions and the use of advanced numerical fate and transport methods to estimate the delivered dose metrics37,54. Here we provide a detailed protocol for such a methodology, which if adopted could ensure consistent test ENM suspensions for in vitro toxicological testing across laboratories and accurate calculation of dose metrics as a function of exposure time in an in vitro culture system.\nDevelopment of the protocol based on the integrated in vitro dosimetry methodology We present here a multistep in vitro dosimetric protocol that enables nanotoxicologists to quantify delivered dose metrics as a function of time54. This protocol consists of three interconnected parts: (i) ENM dispersion preparation; (ii) ENM dispersion characterization; and (iii) numerical fate and transport modeling to derive delivered dose metrics (Fig. 1). We explain these in more detail below.\nPart 1: ENM dispersion preparation. A reproducible dispersion preparation includes two key components: (i) calorimetric calibration of the sonication equipment and reporting of the delivered\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\nnature protocols | VOL.12 NO.2 | 2017 | 357\nsonication energy (DSE) and duration in units of J/ml, and (ii) determination of the material-specific critical delivered sonication energy (DSEcr) required to achieve a suspension with the smallest possible agglomerates that are minimally polydisperse and maximally stable over time. Importantly, sonication must be performed in water rather than in culture media in order to avoid generation of reactive oxygen species by sonolysis and denaturing of proteins33. To generate dispersions in media for use in experiments, the material is first sonicated in deionized water with a delivered sonication energy (J/ml) equal to DSEcr, and subsequently diluted in cell culture media to the desired initial concentration for application to cells (Fig. 2).\nPart 2: ENM dispersion characterization. Characterization has become an increasing concern in ENM toxicological testing33,61–66. Robust characterization, including physical, chemical, and morphological properties of ENM powders, as well as colloidal properties of suspended ENMs, is essential for understanding biointeractions with cells. Lack of suitable ENM characterization, either of the pristine nanomaterials or of the dispersions, can call into question the validity and interpretability of in vitro toxicity data. Recent work by Warheit and Donner and others emphasizes the necessity of establishing and adopting standardized experimental procedures in order to make reliable toxicological determinations53,67,68. A summary of pristine ENM properties commonly evaluated is presented in Table 1. Here we will focus on the colloidal properties of ENM suspensions that drive particle transport in liquid suspension, and thus determine the dose delivered to cells in vitro, namely the size (diameter) and effective density of the formed agglomerates. In the protocol presented here, we describe measurement of size distribution by dynamic light scattering (DLS), and measurement of effective density using the VCM. However, as discussed in more detail below, there are a variety of other instruments and methods available for accurately measuring size and effective density that can be used in place of the specific methods presented in this protocol.\nAlthough analytical ultracentrifugation (AUC) is the gold standard for measurement of ENM effective density, it requires relatively expensive equipment not available in many labs and\nis limited in terms of throughput. The VCM was developed by the authors to allow high-throughput measurement of effective density using a standard bench-top centrifuge and relatively inexpensive packed cell volume (PCV) tubes36. Figure 3 presents a schematic overview of effective density measurement using the VCM. A known volume of suspension of a known ENM concentration is loaded into a PCV tube and centrifuged to collect the agglomerates in the capillary section of the tube. From the measured volume of the pellet and known volume of ENM, the effective density can be calculated as a weighted average of media and ENM.\nPart 3: Fate and transport modeling for calculation of dose delivered to cells. With the stable suspension created and characterized, numerical modeling can then be used to compute the delivered dose metrics as a function of exposure time. The 1D model presented here, referred to as the DG fate and transport model, provides both deposition and concentration metrics, and concentration profiles of ENMs across the well as a function of time37. The DG model also allows modeling of variable binding kinetics at the bottom of the well, accommodates simultaneous simulation of polydisperse suspensions, and allows modeling of dissolution for soluble or partially soluble ENMs. The program is implemented in MATLAB, and it typically runs in a few minutes before exporting dose metrics to an Excel file.\nThe entire integrated methodology, as well as its core components, has previously been experimentally validated, as described in below in detail, for a variety of metal and metal oxide ENMs36,37,54,55, and is suited to most low-aspect-ratio nanomaterials.\nComparison with other methods Several groups have recently proposed standardized dispersion protocols that result in reproducible and stable nanoparticle dispersions in media relevant for in vitro toxicity studies33,69–73. Review of these proposed standardized protocols highlights the key elements necessary for achieving and characterizing reproducible, stable, and relatively monodisperse suspensions for in vitro toxicity testing68. The protocol detailed here draws on best practices identified from those protocols, and it achieves similar\nPart 1: ENM dispersion preparation\nBefore sonication After sonication\n• Determine critical DSE (DSEcr) in water • Sonicate above DSEcr in water • Dilute in physiological media\nPart 2: ENM dispersion characterization\nProtein Corona\nHydrodynamic diameter\n• Determine size distribution (e.g., DLS, AUC) • Determine effective density (VCM, AUC)\nPart 3: fate and transport modeling\nAdministered dose Delivered dose\nComputational fate and transport (particle kinetics) modeling (DG model, ISDD) to determine delivered-dose metrics.\nFigure 1 | Harvard dispersion dosimetry protocol (HDDP). A hybrid experimental and computational approach for determining accurate dosimetry for the in vitro toxicology study. The protocol includes three major parts illustrated here: ENM dispersion preparation, characterization of the ENM dispersion (hydrodynamic diameter and effective density), and computational fate and transport modeling to determine dosimetry.\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\n358 | VOL.12 NO.2 | 2017 | nature protocols\nresults in terms of agglomerate size, size distribution, and agglomerate stability over time33.\nIn addition to DLS, the agglomerate size distribution can be measured using a variety of methods, including AUC, hydrodynamic chromatography, nanoparticle tracking analysis, laser diffraction spectrometry, X-ray disc centrifugation, and tunable resistive pulse sensing38,54,74. Because DLS is easy to use and available in most nanotoxicology labs, and DLS output is suitable and has been validated for computational fate and transport modeling (see discussion of validation of computational modeling based on DLS measurements of size distribution below)36,37,54,55, our protocol uses this method of size characterization. However, any of the other available methods for size characterization may be substituted for the DLS characterization presented here.\nSonicator calibration\nInsert probe in center of tube through opening in cap\nSonicate the water and record the temperature as a\nfunction of time\nFrom the slope of the T vs. t plot, calculate the delivered acoustic power (W = J/S)\nTe m\npe ra\ntu re\n( K\n)\n� = ∆T ∆t\nTime (s)\nDetermine critical delivered sonication energy\nDLS, AUC, and so on\nAdd the nanoparticles\nin Dl water\nSonicate for t min and measure the hydrodynamic diameter (d). Repeat the\ncycle until the dH value fails to reduce further\nDSE (J/ml)\nD S\nE cr\nDetermine the critical DSE (DSEcr) and dilute in media. Check size stability of agglomerate size\nat 24 h. Repeat prior steps if not stable\nH yd\nr. di\nam et\ner (\nnm )\nNanoparticle suspension preparation and cell exposure\nAdd the nanoparticles\nin Dl water Sonicate at DSEcr Dilute in media and vortex to mix Use the nanoparticle suspension to expose the cells\nCells\nNanoparticle suspension\na\nb\nc\nFigure 2 | ENM dispersion protocol. Key steps in the preparation of ENM dispersions include initial calibration of sonication equipment to determine delivered sonication energy, and determination of the critical sonication energy (DSEcr) required to produce the smallest and most stable dispersion of the specific ENM. Preparation of ENM suspensions for application to cultured cells in in vitro experiments is then performed by sonicating in water at levels above the DSEcr and diluting to the desired concentration in the culture medium. dH, hydrodynamic diameter measured by DLS; Hydr., hydrodynamic.\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\nnature protocols | VOL.12 NO.2 | 2017 | 359\nMeasurement of effective density has presented a greater challenge. Despite its importance as a determinant of particle fate and transport, effective density is rarely characterized or reported for nanoparticle suspensions used in cellular toxicity studies68. This parameter can be empirically estimated based on a theoretical fractal-based model for agglomeration75, or it can be calculated from the sedimentation coefficient measured by AUC76. Although AUC provides accurate direct measurement of effective density, the utility of this technique is hindered by the need for expensive laboratory equipment not often found in nanotoxicology labs, and by relatively low throughput. This protocol therefore provides detailed instructions for the recently developed VCM—an inexpensive, accessible, and high-throughput method for measuring effective density. In previous publications, we have validated VCM measurements of effective density against gold-standard AUC measurements for a variety of both high- and low-density particles, as well as for the suitability of VCM measurements for validated computational modeling of particle fate and transport in vitro (see validation of computational modeling based on VCM measurements of effective density below)36,37,54,55. Nevertheless, AUC remains a gold standard for the determination of effective density, and it can be used in place of the VCM approach presented in this protocol.\ntable 1 | ENM properties relevant for in vitro nanotoxicology.\nGeneral properties specific properties Methods notes\nPhysical and morphological Density Pycnometer Relevant for attributing particle properties to biological responses\nSurface area BET1\nPorosity BET/alkaline homologous series\nSurface roughness BET/Anvir and Pfieffer method\nCharge Faraday pail device\nCrystal structure XRD2, TEM–SAD3\nSize XRD–Rietveld analysis, BET, TEM\nShape, aspect ratio TEM–image analysis\nSize distribution TEM–image analysis\nChemical Composition ICP–MS4, TEM–EDS5, TGA6, EC–OC7, Raman spectroscopy (carbon ENMs), FTIR8 (cellulose)\nSurface chemistry. FTIR, XPS9\nMolecular weight ICP–MS (metals and oxides); weight analysis (oxides)\nHydrophobicity/hydrophilicity Dye adsorption; octanol–water affinity\nColloidal Size distribution DLS10, TRPS11, DC12, TEM Relevant for in vitro dosimetry\nPolydispersity DLS, TRPS\nEffective density VCM13, AUC14\nDissolution ICP–MS\npH pH meter Relevant for particle–media interactions and biological responses\nCorona DLS, ELS, LC–MS/MS15\nSpecific conductance DLS\nZeta potential ELS16, TRPS 1Brunauer–Emmett–Teller, 2X-ray diffraction, 3TEM–selected area diffraction, 4Inductive coupled plasma mass spectroscopy, 5Transmission electron microscopy–electron dispersive spectroscopy, 6Thermogravitational analysis, 7Elemental carbon–organic carbon analysis, 8Fourier transform infrared spectroscopy, 9X-ray photoelectron spectroscopy, 10Dynamic light scattering, 11Tunable resistive pulse sensing, 12Disc centrifugation, 13Volume centrifugation method, 14Analytical ultracentrifugation, 15Liquid chromatography–tandem mass spectrometry, 16Electrophoresis light scattering.\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\n360 | VOL.12 NO.2 | 2017 | nature protocols\nThe first computational model for estimating fate and transport of ENMs in vitro was the ISDD model, reported by Hinderliter et al.77, which made it possible to calculate the per well bottom surface area deposited mass, surface area, and number of particles, as well as the fraction of total suspended material deposited as a function of time. This provided a ground-breaking improvement in dosimetry accuracy and enabled meaningful hazard rankings among ENMs. The ISDD model was subsequently adapted to utilize the VCM effective density, is now referred to as the VCM– ISDD54. The DG model developed by the authors and used in the protocol presented here provides deposition, as well as concentration metrics as a function of time, both at the bottom of the well and as a function of position in the well37. As mentioned above, the DG model also allows simultaneous simulation of all particles sizes in the distribution of a polydisperse suspension, and modeling of soluble materials. The DG model also allows modeling of variable binding kinetics (‘stickiness’) at the bottom of the well, based on a user-defined dissociation constant, KD. As described in detail in our original report of the model, lower boundary binding kinetics can substantially affect delivered dose metrics37. Specifically, a perfectly sticky boundary, as used by the ISDD model, can overestimate the rate of particle settling, particularly for relatively small and light particles.\nAs described in detail in the original report, the integrated methodology presented here, including ENM dispersion preparation, characterization, and dosimetry using the DG model, was validated by comparing predicted concentration profiles along the vertical axis for suspensions of metal oxide ENMs with empirical measurements of ENM concentration in thin cryosections from flash-frozen cylinders of ENM suspensions37. In addition, goldstandard 3D computational fluid dynamics (CFD) models were developed and used to validate the DG model and the integrated methodology presented here. Very close agreement was observed between empirical cryosection measurements and both the DG and CFD model predictions. The methodology had been further validated by our lab in terms of predicting biological outcome in an in vitro study of the hazard ranking of a large panel of lowaspect-ratio ENMs53. Details on the validation of this integrated in vitro dosimetry methodology can be found in papers previously published by the authors33,36,37,53."
    }, {
      "heading" : "Experimental design",
      "text" : "Although the multistep protocol described above is suitable for the majority of ENMs, in some circumstances it may be necessary to adapt the protocol to accommodate the specific characteristics of the ENM being used. ENMs that may require modification of the protocol include those that are substantially soluble, those that form particularly large agglomerates, and those that are buoyant.\nThe dissolution of ENMs over time can have important effects on properties of ENM dispersions and fate, and transport modeling, and must be taken into account for soluble materials (e.g., Ag, ZnO). For metal and metal oxide ENMs, dissolution over time can be determined by using one of several available techniques, including ultracentrifugation, either alone or combined with ultrafiltration78,79, and dialysis79–81, to remove undissolved particles, and subsequently quantifying the dissolved metal concentration in the resulting supernatants, ultrafiltrates, or dialysates by inductively coupled plasma mass spectrometry.\nThe dissolved concentrations can then be used to determine the dissolved fraction and make the necessary adjustments to characterization and particle kinetics modeling and dose metrics, as described in detail below.\nSome ENMs may also form large agglomerates containing very high amounts of medium, such that the total agglomerate volume is large, and it may block or overfill the PCV tube capillary. In these cases, it may be necessary to repeat the protocol using a lower concentration, or to use alternative methods such as AUC to estimate effective density. At the other extreme, ENMs that form small agglomerates may require longer than the 1 h recommended (at 3,000g) in this protocol to become completely pelleted. For example, given a VCM liquid column height of 3 cm, particles with a typical average effective density of 1.5 g/ml and diameter of 200 nm would require ~13 min to become pelleted, and those with a diameter of 100 nm would require 50 min. However, particles with a diameter of 50 nm would require 198 min to become pelleted (~3.3 h). This time would be further increased for ENMs forming agglomerates with lower effective densities (sedimentation velocity is proportional to the difference between medium density and ENM agglomerate effective density). Thus, when working with ENMs that form small and/or low-density agglomerates, the centrifugation time for the VCM method may need to be increased substantially, and in some cases in which particles are smaller than ~50 nm, and/or have relatively low effective densities, it may be more efficient and practical to use AUC to determine effective density.\nBuoyant ENMs with density less than that of the medium require adaptation of the VCM method or use of an alternative method (e.g., AUC) for measurement of effective density. Because buoyant ENM agglomerates move toward, rather than away from,\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\nnature protocols | VOL.12 NO.2 | 2017 | 361\nthe rotor center during centrifugation, it is necessary to perform the VCM with the PCV tubes inverted in the centrifuge. Detailed methods for making these modifications and measuring effective density of buoyant particles are included in a newly published paper by the authors46, and will not be presented here.\nNo specific controls are required for the dispersion preparation and determination of size by DLS, for effective density by the VCM method, or for subsequent dosimetry modeling. However, it is important that DLS instrumentation be regularly maintained, calibrated, and validated according to the manufacturers’ guidelines. For example, standard particles of known size are available from manufacturers of DLS instruments, and they should periodically be used to verify that the instrument is correctly measuring hydrodynamic diameters within the tolerance specified by the manufacturer.\nFinally, the type of cell culture system and specific cells types used for in vitro testing depend on the exposure type being emulated (e.g., inhalation, dermal exposure, ingestion) and specific types of effects being investigated. For example, common immortal cell lines used for investigating possible effects of inhalation exposure include human small airway epithelial cells, human microvascular endothelial cells, and human THP-1 macrophages26,55,60,82. However, it is worth noting that the proposed methodology and protocols are independent of cell type and cellular assays."
    }, {
      "heading" : "Limitations",
      "text" : "The proposed standardized methodology is limited to relatively low-aspect-ratio ENMs. Although this includes the vast majority of metal, metal oxide, and many carbon-based ENMs, as well as incidental nanoparticles (e.g. resulting naturally via combustion processes) and particles released across the life cycle of NEPs, this methodology is not suited to high-aspect-ratio carbon nanotubes (CNTs) or other 2D ENMs such as graphene. This is because (i) dispersion of hydrophobic ENMs such as CNTs and graphene in aqueous media might be difficult using the approach described in part 1, as it often requires the use of specially designed surfactants or other novel dispersants83,84; and (ii) the sedimentation and diffusion equations underlying fate and transport modeling assume that particles or agglomerates can be approximated as spheres with a given hydrodynamic diameter. The hydrodynamic diameter, which is the product of the diameter of the sphere of equivalent volume and a frictional coefficient that accounts for nonspherical shape and surface irregularity, is used to calculate both the sedimentation and diffusion coefficients needed to model transport. Hydrodynamic diameter can be measured directly by methods such as DLS, and it can often be estimated for nonspherical shapes when only the equivalent diameter is known. For prolate or oblate ellipsoids, or rigid rods, for example, it is possible to approximate frictional coefficients in order to arrive at hydrodynamic diameters and enable fate and transport modeling using the DG model. However, for very long rods (nonagglomerated CNTs), or non-rigid or branching structures (e.g., nanofibrillar cellulose), the situation is more complex, and fate and transport modeling approaches have as yet not been worked out. In such cases, it may be possible to use an empirical method, such as flash-freezing columns of suspension at various time points, cryosectioning those frozen columns, and applying various methods to quantify the content of the nanomaterial in each section. Investigations into the internalized particle dose via mass spectrometry85, or tracking of cellular uptake of fluorescent-labeled or radiolabeled particles55 may provide alternative approaches for estimating dosimetry in these cases. Similarly, the ENM suspension preparation protocols described here may not be suitable to generating relatively monodisperse suspensions for such high-aspect-ratio and hydrophobic ENMs. More research is needed to determine suitable methods for preparing and characterizing suspensions and performing dosimetry analysis for such ENMs."
    }, {
      "heading" : "MaterIals",
      "text" : ""
    }, {
      "heading" : "REAGENTS",
      "text" : "Sterile deionized water Cell culture medium of choice (for example, RPMI 1640, Thermo Fisher Scientific, cat. no. 11875093, or DMEM, Thermo Fisher Scientific, cat. no. 11995065, supplemented with 10% (vol/vol) FBS, Thermo Fisher Scientific, cat. no. 16000044) ENMs: the protocol described can be successfully applied to all lowaspect-ratio ENMs, including metal and metal oxide ENMs obtained from commercial vendors (for example, Sigma-Aldrich Fe2O3, cat. no. 544884, and TiO2, cat. no. 637262) or produced industrially or in the laboratory by methods such as flame spray pyrolysis (for example, as generated by the Harvard versatile engineered nanomaterial generation system (VENGES)86 as described previously42,86,87, or generated during use or disposal of NEPs and ambient nanoparticles collected from air samples25,88\nEQUIPMENT High-precision laboratory scale or analytical balance (for example, Mettler Toledo XPE205DR, cat. no. 30087700) Sonicator (for example, Branson Sonifier S-450D, 400 W; Branson, cat. no. 101-063-590)  crItIcal a minimum power rating of 250 W is recommended to allow reasonable sonication times, and it may be necessary to achieve adequate dispersion. Sonicator cup horn (for example, Branson 3-inch inside diameter, flow through; Branson, cat. no. 101-147-048) Small three-prong dual-adjust clamp (e.g., Southern Labware, SKU 916056) Flexible PVC tubing for connecting water source to cup horn inlet and cup horn outlets to drain. For the Branson 3-inch inside diameter cup horn,\n• •\n•\n•\n•\n•\n• •\na tubing with an inside diameter of 3/8 inch is required (for example, VWR Signature Clear PVC Tubing, inside diameter 3/8 inch, 50 feet, cat. no. 60985-540) Sound enclosure for sonicator setup (for example, Branson, cat. no. 101-063-275) 15-ml and 50-ml conical polypropylene or polystyrene centrifuge tubes (for example, Falcon, cat. nos. 352097 (15 ml) and 352070 (50 ml)) Laboratory vortex mixer (for example, VWR, cat. no. 97043-562) DLS instrument (for example, Zetasizer Nanoseries Nano ZS; Malvern, or any other colloidal nanoparticle-size characterization instrument) TPP PCV tubes without graduations (TPP Techno Plastic Products, cat. no. 87005) and caps (TPP Techno Plastic Products, cat. no. 87008) Easy-read measuring device for PCV tubes (TPP Techno Plastic Products, cat. no. 87010) Laboratory centrifuge (for example, Beckman Coulter Allegra 6, cat. no. 366802) Swinging-bucket rotor (for example, Beckman Coulter GH-3.8A, cat. no. 366650)  crItIcal Rotor must be swinging-bucket style, not fixed-angle style. Microtube-size bucket adaptor (for example, Beckman Coulter, cat. no. 359469) Viscometer with a range of ≤0.5 to ≥2.0 cSt (for example, size 25 Cannon-Fenske tube viscometer; Sigma-Aldrich, cat. no. Z275263) PC running Windows 7 or 10, minimum 4 GB RAM MATLAB core product for Windows, version 2013a or later; no toolboxes are required (https://www.mathworks.com/products/matlab.html) Microsoft Excel 2010 or later • • • • • • • • • • • • •\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\n362 | VOL.12 NO.2 | 2017 | nature protocols\nDG model .m file: DG_nanotransport_simulator.m (provided as Supplementary Software)\nEQUIPMENT SETUP Sonicator setup The following instructions describe the general setup of the Branson S-450D Sonifier with Branson 3-inch cup horn. Consult the product manual for detailed instructions for this and any other devices. Connect the • sonicator cup horn to the converter, and the converter to the power supply (i.e., the Branson S-450D). Secure the cup horn within the acoustic enclosure. Connect the cup horn coolant inlet port to a cold-water source, and connect the outlet and overflow ports to a drain using 0.25-inch plastic tubing (for the Branson 3-inch cup horn). Adjust the three-pronged clamp to hold conical centrifuge tubes in the center of the cup horn.\nproceDure part 1: enM dispersion preparation ● tIMInG 2.5–5 h  crItIcal As described in ‘Equipment Setup’, the sonicator must be calibrated calorimetrically before use to ensure that the exact delivered sonication energy is known and reported for any experiment. This will also ensure that sonicators from different manufacturers or models can be used to deliver the specific sonication energy of interest. 1| Sonicator calorimetric calibration to obtain DSE rate (DSE/min). Drill a hole that is large enough for the thermometer probe (a suitable hole can be created with a box cutter) in the cap of a 50-ml conical centrifuge tube.\n2| Add 50 ml of deionized water to the 50-ml conical centrifuge tube.\n3| Insert the thermometer probe through the hole and into the water in the tube.\n4| Turn the thermometer on.\n5| Position and secure the tube in a three-pronged clamp in the center of the cup horn.\n6| Turn the sonicator power on, and select and record power settings (for example, 75% amplitude, continuous mode).\n7| Turn on the cup horn water source and adjust flow so that the sample meniscus is aligned with the water level in the cup.\n8| Turn the sonicator power on.\n9| Record the temperature every 10–30 s until the temperature stabilizes (~3–5 min), and then turn the sonicator power off. ? troublesHootInG\n10| Repeat Steps 2–9 two times to generate a total of three data sets.\n11| Calculate the delivered acoustic power P(W = J/s) as\nP dT dt MCp= ( / )\nwhere dT/dt is the slope of temperature (K) vs. time (s), M is the mass of water (5 g for 5 ml deionized water), and Cp is the specific heat of water (4.186 J/g °K).\n12| Calculate and record the average power, P(J/s), from the three measurements (for the specific sonicator and sonicator settings used).\n13| Determination of DSEcr. Weigh ~1 mg of nanoparticle powder into a 15-ml conical centrifuge tube.\n14| Add deionized water to achieve a final concentration of 0.5 mg/ml.\n15| Vortex the suspension at high speed for 30 s.\n16| Remove 1 ml of the suspension, measure the mean hydrodynamic diameter using DLS or other size characterization instrumentation, and return the sample to the tube.\n17| Adjust the sonicator power settings to those used during calibration (Step 6), and turn the sonicator power on.\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\nnature protocols | VOL.12 NO.2 | 2017 | 363\n18| Sonicate the particle suspension for 1–2 min.\n19| Calculate DSE (J/ml) for the sonication step as\nDSE P t V= × /\nwhere P is the delivered acoustic power determined in the calibration steps (Steps 1–12), t is time in seconds, and V is the volume of the suspension in milliliters.\n20| Remove 1 ml of the suspension, measure the mean hydrodynamic diameter using DLS or other size characterization instrumentation, and return the sample to the tube.\n21| Repeat Steps 18–20 until the mean hydrodynamic diameter decreases by <5% between steps.\n22| Plot cumulative DSE (x axis) vs. mean hydrodynamic diameter (y axis).\n23| Identify the DSEcr (J/ml) as the cumulative DSE at which further sonication does not further reduce the mean hydrodynamic diameter by more than 5% (slope approaches zero).\n24| Remove a 100-µl sample of suspension, dilute it to 100 µg/ml in the culture medium of choice, and measure the mean hydrodynamic diameter of the sample by DLS or other size characterization instrumentation.\n25| Repeat size measurement of suspension in culture medium at 24 h.  crItIcal step If the mean size changes substantially (by more than 30%) at 24 h, it may be advisable to repeat Steps 13–25 with additional sonication time until the 24-h postsonication suspension mean size is more consistent with that at time 0. DSEcr refers to the energy per unit volume of suspension required to achieve the smallest possible agglomerates and most stable suspensions over time. Although some change in size over time due to re-agglomeration is not uncommon, large deviations in mean size indicate an unstable suspension, suggesting that additional power is needed to completely disrupt the forces between primary particles.\n26| Preparation of suspensions for characterization and use in experiments. Weigh the amount of nanoparticle powder required for the experiment into a 15-ml conical centrifuge tube.\n27| Add deionized water to achieve a final concentration of 0.5 mg/ml.  crItIcal step Maximum volume for sonication in a typical 3-inch cup horn is ~5 ml. It may not be possible to effectively deliver energy to suspensions of greater volume. If larger amounts of suspension are required, split them into portions of 5 ml each.\n28| Vortex the suspension at high speed for 30 s.\n29| Select the sonicator power settings and turn the sonicator power on.  crItIcal step Use the same power settings used to calibrate sonicator and to measure DSEcr.\n30| Calculate time t (s) required for sonication as\nt V DSE Pcr= × /\nwhere V is the volume of suspension (ml) and P is the delivered power (W or J/s) determined by calibration (Steps 1–12).\n31| Sonicate the suspension for the calculated time required.\n32| Vortex the suspension at high speed for 30 s\n33| Dilute to the final desired concentrations in the medium or in the fluid of choice for characterization or experimental studies.\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\n364 | VOL.12 NO.2 | 2017 | nature protocols\npart 2: enM dispersion characterization ● tIMInG 3–5 h  crItIcal Note that effective density can alternatively be measured by AUC. 34| Determination of suspended nanomaterial effective density (ρEV). Dilute water suspension prepared as described above in desired medium to make ~4 ml of suspension at 100 µg/ml.\n35| Transfer 1 ml of suspension to each of three PCV tubes, and cap the tubes.\n36| Centrifuge the tubes at room temperature (22 °C) for 1 h at 3,000g.\n37| Use the ‘easy-read’ measuring device to measure the volume of the pellet collected at the bottom of the capillary in each PCV tube. The device resembles a thick ruler. The front face is etched along the top with graduations at 0.025-µl intervals. Insert the PCV tube into the hole on top of the sliding holder so that it rests on the ramp at the back of the ruler. The holder contains a lens to magnify the capillary and ruler graduations. Slide the tube and holder along the ramp until the top edge of the pellet is aligned with the top edge of the ruler. Position your line of sight so that the horizontal crosshair is aligned with the top edge of the ruler, and the vertical line of the crosshair is aligned with the capillary center. If not properly aligned, parallax error will result in measurement error (Fig. 3b).  crItIcal step It is important to use the easy-read device correctly to avoid errors. ? troublesHootInG\n38| Calculate density of the medium, ρmedia (g/cm3), by weighing a known volume of medium in a tared vessel, or by subtracting the mass of a preweighed vessel from the mass of the vessel with the medium and dividing by the volume.\n39| Calculate the effective density, ρEV, for each measured pellet volume using the following equation:\nr r r rEV media ENM ENMsol\npellet\nmedia\nENM\nM M V SF = + −  \n   −  \n \n  1 \n   \nwhere ρmedia is the density of the medium (g/cm3), MENM is the total mass of nanomaterial (g) in the dispensed volume (1 ml) of suspension (e.g., 1.0 ml × 100 µg/ml × 1 × 10−6 g/µg = 1.0 × 10−4 g), and MENMsol is the mass of dissolved nanomaterial (g) in the dispensed volume (1 ml) of suspension. For insoluble materials, MENMsol is 0. For soluble materials, MENMsol must be determined by analyzing the supernatant (e.g., by inductively coupled plasma mass spectrometry) of an ENM suspension after centrifugation. Dissolution measurements are beyond the scope of this paper, but suitable methods can be found in numerous sources in the literature78–81. From the concentration of dissolved ENM, the mass of dissolved ENM can be calculated (e.g., 1.0 ml × 10 µg/ml × 1 × 10−6 g/µg = 1.0 × 10−5 g); Vpellet is the measured pellet size in centimeters squared (convert measured volume, which is in microliters or millimeters squared, to centimeters squared by dividing by 1,000), and ρENM is the density (g/cm3) of the raw nanomaterial (e.g. 5.242 g/cm3 for Fe2O3). SF is the stacking factor, which is the portion of the pellet that is composed of agglomerates (the remaining portion being inter-agglomerate medium). Values for SF may range from 0.634, for random stacking, to the theoretical maximum of 0.74, for ordered stacking89,90. For the roughly spherical agglomerates typically observed with low-aspect-ratio ENMs, we have verified that the theoretical value for random close stacking (0.634) is appropriate, whereas for uniform nonagglomerating spherical ENMs (e.g., gold spheres) the theoretical value for ordered stacking (0.74) should be used36.\n40| Calculate the mean ρEV from the three individual measures.\n41| Determination of size (hydrodynamic diameter) distribution. Power on the Zetasizer Nanoseries 30 min before use.  crItIcal step The following steps describe size characterization using a Zetasizer Nanoseries DLS instrument. For other DLS instruments, refer to the manufacturer’s instructions. As discussed in the INTRODUCTION, several other types of instrumentation for measuring colloidal size distribution are available and can be used in place of a DLS instrument.\n42| Turn on accompanying PC or laptop computer and open the Zetasizer software.\n43| Transfer 1.0 ml of sample to a Malvern disposable cuvette.\n44| Insert the cuvette into the DLS machine and close the cover.\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\nnature protocols | VOL.12 NO.2 | 2017 | 365\n45| Select the material–medium-specific standard operating procedure (SOP, which contains material- and medium-specific properties needed by the instrument) if one exists. If no SOP exists for the specific material and medium, create a new SOP by entering the material-specific refractive index and absorption, and the medium-specific viscosity.\n46| Run the SOP to collect the mean hydrodynamic diameter and the intensity-, number-, and volume-weighted size distributions.  crItIcal step The three types of distributions obtained from DLS (intensity-, number-, and volume-weighted) often differ to a certain extent from one another. Specifically, the intensity-weighted distribution can be relatively skewed toward larger sizes, whereas the number distribution can be skewed toward smaller sizes. For calculation of DSEcr, described above (Steps 13–25), the mean hydrodynamic diameter reported by the instrument is used. For fate and transport modeling, described below, the most accurate results are obtained using the volume-weighted distribution, which best represents the mass distribution of the suspended material. ? troublesHootInG\npart 3: Fate and transport modeling for calculation of dose delivered to cells ● tIMInG 30 min–1 h 47| Analysis of particle kinetics and calculation of dose metrics with fate and transport modeling (DG model). Open the .m file DG_nanotransport_simulator.m (supplementary software) in the MATLAB editor.\n48| Enter the solvent/media properties. Each user input data parameter is listed as uid.name, where ‘name’ is a descriptive name of the parameter. ‘uid.’ is a MATLAB data structure, of which all the named parameters are elements. This is followed by the assignment operator ‘=’, a number value, and a closing semicolon; for each parameter, change the associated number value (or values in the case of arrays) to the appropriate datum for your experimental system. A summary of all input parameters is given in table 2. The solvent/media properties to be entered are the solvent viscosity (uid.solvent_viscosity) in Pascal-seconds (Pa s; box 1), the solvent density (uid.solvent_density) in grams per centimeter squared, and the temperature of the system (uid.solvent_temperature) in degrees Celsius.\n49| Enter the particle properties. These include the ENM raw material density (uid.material_density) in grams per centimeter squared, the particle diameters for each particle size species present (uid.particle_diameters) in nanometers, the volume-weighted fraction of the total volume of ENM corresponding to the particle diameters (uid.species_fractions), and the agglomerate or particle effective density (uid.particle_effective_density), in grams per centimeter squared. The particle diameters and corresponding species fractions are arrays, enclosed by square brackets. It is possible to enter a single average particle size, in which case the corresponding species fraction array would contain the single value of 1.0. However, more accurate results can be obtained if the particle size distribution and corresponding fractions (e.g., the volume-weighted size distribution obtained by DLS) are used.\nBox 1 | Determination of media dynamic viscosity Because particle transport rates, both for diffusion and sedimentation, are inversely proportional to media dynamic viscosity, it is important to accurately measure these properties before proceeding to fate and transport modeling. Because viscosity is temperature dependent, it is important that it be measured at the temperature at which the ENM suspensions will be incubated with cells (e.g., 37 °C). For example, at room temperature, the dynamic viscosity of RPMI culture medium supplemented with 10% (vol/vol) heat-inactivated FBS is, by our measurements, 0.00103 Pa s, whereas at 37 °C the viscosity of the same medium is 0.00081 Pa s (22% lower). A number of options are available for measurement of viscosity, including inexpensive glass U-tube (Ostwald or Cannon-Fenske) viscometers, somewhat more expensive falling-ball viscometers, more expensive rotational viscometers, and others. When selecting a viscometer, be sure that it is capable of measuring in the 0.5- to 2.0-centistokes (cSt) range. The viscosity of water at 22 °C is 1.0 cSt, and most biological fluids and culture media have viscosities between 0.75 and 1.25 cSt. Methods for proper use of a viscometer are provided by the manufacturers and will not be presented here. Most viscometers yield the kinematic viscosity v, in the centimeter–gram–second unit cSt. Use the following formula to convert to dynamic viscosity, η, in SI units (Pa s), which is the value required for fate and transport modeling inputs (used within the code for calculation of diffusion and sedimentation coefficients):\nh n r( ) (Pas cST)= × × −10 3\nwhere ρ is the density of the media in kilograms per meter cubed (equivalent to grams per centimeter cubed).\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\n366 | VOL.12 NO.2 | 2017 | nature protocols\n50| Enter the experimental parameters. These include the height of the liquid column within the cell culture well (uid.column_height) in millimeters (e.g., 3.0 mm for a typical 96-well plate with 100 µl of suspension per well), the initial concentration of ENM (uid.initial_concentration) in milligrams per centimeter squared, and the total simulation time (uid.simulation_time) in hours. The simulation time should be set to the duration of the in vitro exposure incubation.\n51| Enter model parameters. These define the resolution in space and time, of the simulation, and usually do not need to be changed from their default values. The model divides the height of the well into a number of small compartments, and performs alternating short rounds of sedimentation and diffusion between these compartments. The compartment height (uid.compartment_height) specifies the height of these small compartments in millimeters. It is usually set to 0.005, and it should not require changing, unless a finer resolution of the vertical concentration profile is desired. The duration of the short rounds of sedimentation and diffusion is specified by the simulation time interval (uid.simulation_time_interval), in seconds. The default is 0.5 s. Larger values (1.0–2.0 s) may reduce the time for the simulation to run; however, this will also reduce the accuracy of the results.\n52| Enter output data parameters. These specify the temporal and spatial resolutions of the dosimetry output data, and options that may save time if only some of the output is required. The output time interval (uid.output_time_interval), in\nBox 2 | Analysis of DG model output data The Excel output file generated by the DG model contains several relevant dose metrics at each output time point (defined by the chosen parameters uid.simulation_time and uid.output_time_interval) during the simulated time. These metrics are summarized in table 2, and include mass, particle number, and surface area concentrations per unit of volume, as well as per unit of well-bottom area, and fraction of administered ENM deposited (within the bottom compartment). For materials that are soluble, the concentration of dissolved material is also provided, and mass concentrations are provided both including and excluding the dissolved-material contribution. In addition, if the simulation includes adsorption (uid.sticky is set to 1), the mass bound per unit of area and the percentage of the bottom occupied by adsorbed particles are provided. The output Excel file contains multiple sheets. In the sheet named ‘Bot Summary’, the dose metrics in table 2 are given for each time point at the bottom of the well (i.e., within the bottom compartment, representing the cell microenvironment, the height of which is defined by the value of the parameter uid.output_compartment_height selected for the simulation—typically 0.01 mm or 10 µm). In addition to the Bot Summary sheet, the DG output file contains one sheet for each of the above parameters, in which the value of the parameter over time is given at the center z position of each compartment (defined by the uid.output_compartment_height value selected when running the simulation).\ntable 2 | Excel output dose metrics for the DG model.\nparameter units Meaning\nMp vol−1 mg/cm−3 Mass of ENM per unit volume, not including dissolved ENM\nMp+DissC vol−1 mg/cm−3 Mass of ENM per unit volume, including dissolved ENM\nFrx Mp N/A Fraction of administered ENM deposited (within compartment, e.g., bottom compartment, cell microenvironment)\nMp area−1 mg/cm−2 Mass of ENM per unit area of well bottom, not including dissolved ENM\nMp+DissC area−1 mg/cm2 Mass of ENM per unit area of well bottom, including dissolved ENM\nNp vol−1 cm−3 Number of particles per unit volume\nNp area−2 cm−2 Number of particles per unit area of well bottom\nSAp vol−1 cm2/cm3 ENM surface area per unit volume\nSAp area−1 cm2/cm−2 ENM surface area per unit area of well bottom\nDissC vol−1 mg/cm−3 Mass of dissolved ENM per unit volume\n% Floor occ. % Percentage of well bottom occupied by adsorbed particles (reported only for uid.sticky = 1)\nMbound area−1 mg/cm−2 Mass of ENM bound to bottom per area of well bottom (reported only for uid.sticky = 1)\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\nnature protocols | VOL.12 NO.2 | 2017 | 367\nminutes, specifies the time between saved data points. The output compartment height (uid.output_compartment_height), in millimeters, is the vertical resolution of the output concentration profile. It is also the height of the bottom compartment, which defines the thickness of the cell microenvironment. Deposition metrics are calculated based on the amount of material in this compartment.\n53| Enter dissolution parameters. If the ENM being analyzed is soluble, and dissolution data have been obtained, they can be entered here. The initial dissolution fraction (uid.initial_dissolution) is the fraction of ENM dissolved at the start of the incubation. The dissolution rate type (uid.dissolution_rate_type) defines the type of dissolution data that will be provided. If no further dilution occurs after the initial dissolution, then the dissolution rate type should be set to 0. If dissolution occurs at a constant rate (a constant fraction of ENM dissolves per unit of time) then the dissolution rate type should be set to 1. If dissolution is not linear, and measurements were made at multiple time points, then the dissolution rate type should be set to 2. The dissolution rate (uid.dissolution_rate) is relevant only when the dissolution rate type is set to 1, and specifies the fraction of the total ENM that dissolves per hour. The last two dissolution parameters, dissolution times (uid.dissolution_times) and dissolution fractions (uid.dissolution_fractions), are relevant if the dissolution rate type is set to 2, and specify the time points and dissolved fractions in the dissolution curve.\n54| Enter particle–cell adsorption parameters. These parameters are used to control whether and with what affinity particles are adsorbed to the cell surfaces at the bottom of the well. The uid.sticky parameter determines whether adsorption occurs (set to 1) or not (set to 0). If this parameter is set to 0, then the value of the second adsorption parameter, the dissociation constant (uid.adsorption_dissociation_constant), in units of molarity, is ignored and irrelevant, and the bottom boundary condition for the simulation is perfectly reflective. If uid.sticky is set to 1, then the degree of stickiness is determined by the dissociation constant. Typically, sizable effects on transport (dose metrics) occur only for dissociation constant values less than ~1 × 10−9 M.\n55| Save changes and execute the .m file. While the simulation is running, the percentage completed will be displayed in the MATLAB command window.\n56| Export the results to an Excel file. When the simulation is complete, a prompt will appear for providing a name and location for the output Excel file. This file contains dose metrics over the course of the simulation time. See box 2 for a description of the file format.\n? troublesHootInG Troubleshooting advice can be found in table 3.\ntable 3 | Troubleshooting table.\nstep problem possible reason solution\nCalibration of sonicator (Step 9) Water temperature rises quickly and levels off, providing limited data points for calibration curve\nA low-volume water sample can absorb a limited amount of energy before reaching thermal equilibrium, at which point the temperature will stop rising\nFor calorimetric calibration, use at least 50 ml of water\nMeasuring of VCM pellet size (Step 37)\nCannot see pellet (i) Insufficient material in suspension to form a visible pellet\nRepeat VCM (Steps 35–38) with a higher concentration of material\n(ii) Small particles (<100 nm) may not reach the bottom of the capillary within 1 h\nIncrease the centrifugation time. If there is no pellet after 4 h, consider using AUC\n(iii) ENM may be buoyant (density less than media density)\nRefer to Watson et al.46 for possible adaptation of VCM method, or use AUC to measure effective density\nPellet clogs the top of capillary or overfills the capillary of the VCM tube\n(i) Total volume of agglomerates may be too large\nRepeat VCM (Steps 35–38) with a lower concentration of material\n(continued)\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\n368 | VOL.12 NO.2 | 2017 | nature protocols\n● tIMInG part 1: enM dispersion preparation, 2.5–5 h Steps 1–12, calibration of the sonicator: 1–2 h Steps 13–25, determination of DSEcr: 1–2 h Steps 26–33, preparation of suspensions for experiments: 30 min–1 h part 2: enM dispersion characterization: 3–5 h Steps 34–40, determination of effective density: 2–4 h Steps 41–46, determination of size distribution by DLS: 1 h part 3: fate and transport modeling for calculation of dose delivered to cells, 30 min–1 h Steps 47–56, particle kinetics and dosimetry: 30 m–1 h\nantIcIpateD results The step-by-step protocol detailed above can be used to determine in vitro dose metrics for most low-aspect-ratio ENMs, including incidental nanoparticles (e.g., resulting naturally via combustion processes) and nano-sized particles released across the life cycle of NEPs.\nTo illustrate the use of this protocol with a typical ENM, we provide here highlights for a case study using a common metal oxide ENM (Fe2O3) to determine dose metrics in a 96-well plate over 24 h. The Fe2O3 material for this case study was made by flame spray pyrolysis using the Harvard VENGES86, as described previously42,86,87. The powder characterization and colloidal characterization in DMEM + 10% (vol/vol) FBS for this material are presented in table 4. The sonicator used was a Branson model S-450D with 3-inch inside-diameter cup horn, which was calibrated using Steps 1–12 and determined to deliver a power of 2.59 J/s.\nDetermination of critical delivered sonication energy (Dsecr) The DSEcr value for the Fe2O3 material was determined following Steps 13–25. Mean hydrodynamic diameter (obtained by DLS) is shown plotted as a function of applied energy in Figure 4. From this graph, we determined that the DSEcr value for the material is 345 J/ml. The mean hydrodynamic diameter in medium immediately after dilution was determined by DLS to be 976 nm. At 24 h after dispersion in medium, the mean hydrodynamic diameter was found by DLS to be 717 nm, suggesting that the formed agglomerates were not perfectly stable. As the difference was within 30%, it was deemed acceptable. It is possible that in some cases sonication in water for a longer time (selecting a higher DSEcr value) will further improve stability of the suspension in medium. For this material, sonication at a higher DSE value did not improve the stability of the media suspension (data not shown).\ntable 4 | Fe2O3 ENM characterization.\nenM powder properties colloidal properties in DMeM + 10% (vol/vol) heat-inactivated Fbs\nssa (m2/g) dbet (nm) dXrD (nm) dH (nm) pdI  (mV)  (ms/cm) eV\n54.7 20.9 27.2 976.0 0.40 −14.4 13.8 1.483 ζ, zeta potential; σ, specific conductance; ρEV, effective density measured by VCM; dBET, primary particle diameter determined from SSA; dH, hydrodynamic diameter measured by DLS; dXRD, particle diameter measured by X-ray diffraction; PdI, polydispersity index; SSA, specific surface area measured by nitrogen adsorption by the Brunauer–Emmet–Teller (BET) method.\ntable 3 | Troubleshooting table (continued).\nstep problem possible reason solution\n(ii) Agglomerates are too large to enter the capillary tube\nVCM cannot be used. Use an alternative method, such as AUC, to determine effective density\nPellet is lodged on the side of the VCM tube\nCentrifuge bucket was not horizontal during centrifugation (e.g., a fixed-angle rotor was used)\nRepeat VCM using a swingingbucket rotor\nMeasuring of particle size (DLS; Step 46) Multimodal size distribution Dispersion was not sonicated sufficiently\nPrepare fresh solution with dispersion sonicated to the materialspecific critical delivered sonication energy (DSEcr)\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\nnature protocols | VOL.12 NO.2 | 2017 | 369\ncolloidal characterization of the enM suspension: effective density and size distribution The effective density (ρEV) for the Fe2O3 ENM in DMEM + 10% (vol/vol) FBS was measured using the VCM according to Steps 34–40. The density of the medium, total and dissolved mass of ENM, raw ENM density, and SF used in the calculation of effective density were as follows:\nρmedia = 1.0084 g/cm3. MENM = 1.0 ml × 100 µg/ml × 1 × 10−6 g/µg = 1.0 × 10−4 g. MENMsol = 0.0 g (insoluble material). ρENM = 5.242 g/cm3 (Fe2O3). SF = 0.634.\nThe three measured pellet volumes and calculated effective densities are shown in table 5. The mean effective density\nfrom these three measurements was 1.483 g/cm3. The size distribution of the suspension was measured by DLS (Steps 41–46) and is represented in Figure 5.\nanalysis of particle kinetics and calculation of dose metrics with fate and transport modeling The effective density- and volume-weighted size distribution determined above were used to determine dose using the DG model. In the MATLAB file ‘DG_nanotransport_simulator.m’ (supplementary software), the list of sizes and corresponding volume-weighted fractions (from DLS), and effective density have been assigned to the relevant variables, and all other variables have been set as described above in Steps 48–54. The simulation was then run, and data were exported to the file ‘DG_output_Fe2O3_CaseStudy.xlsx’ (supplementary Data). The output metrics described above in box 2 and table 2 can be found in this file. As described in box 2, all metrics at the bottom of the well are presented in the ‘Bot Summary’ tab, and there are additional tabs for each metric that provide each metric as a function of both time and vertical position in the well. The mean for each metric has been calculated and added to the Bot Summary tab. The fraction deposited and mass concentration vs. time plots automatically generated by the program are shown in Figure 6. From these plots, it is clear that the agglomerates sediment relatively quickly to reach a maximum equilibrium concentration at the bottom of the well (24.8 mg/ml) and fraction deposited (0.82) at ~11 h. The mean concentration at the bottom of the well (22.7 mg/ml) and mean fraction deposited (0.76) over the simulated exposure time are also presented in the output graphs in Figure 6.\n1,000\n750\n500\n250\n0 200 400 600\nDSE (J/ml)\nDSEcr = 345 J/ml\nd H\nFigure 4 | Determination of DSEcr value. Mean hydrodynamic diameter as a function of dispersion sonication energy. dH, hydrodynamic diameter measured by DLS.\ntable 5 | Calculation of effective density.\nVpellet (cm3)\nρ ρ ρ ρEV media ENM ENMsol\npellet\nmedia\nENM\nM M V SF = + - -        \n \n  1 \n   \n(g/cm3)\n2.75 × 10−4 1.427\n3.0 × 10−4 1.433\n2.375 × 10−4 1.545 V, volume.\n25\n0.9\na b\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\n370 | VOL.12 NO.2 | 2017 | nature protocols\n21. Lai, D.Y. Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4, 1–15 (2012). 22. Warheit, D.B., Borm, P.J.A., Hennes, C. & Lademann, J. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop. Inhal. Toxicol. 19, 631–43 (2007). 23. Keller, A.A., McFerran, S., Lazareva, A. & Suh, S. Global life cycle releases of engineered nanomaterials. J. Nanopart. Res. 15, 1692 (2013). 24. Wigger, H. et al. Influences of use activities and waste management on environmental releases of engineered nanomaterials. Sci. Total Environ. 535, 160–71 (2015). 25. Pirela, S.V et al. Development and characterization of an exposure platform suitable for physico-chemical, morphological and toxicological characterization of printer-emitted particles (PEPs). Inhal. Toxicol. 26, 400–8 (2014). 26. Sisler, J.D. et al. Small airway epithelial cells exposure to printer-emitted engineered nanoparticles induces cellular effects on human microvascular endothelial cells in an alveolar-capillary co-culture model. Nanotoxicology 9, 769–79 (2015). 27. Sotiriou, G.A. et al. An integrated methodology for the assessment of environmental health implications during thermal decomposition of nanoenabled products. Environ. Sci. Nano 2, 262–272 (2015). 28. Wohlleben, W. et al. On the lifecycle of nanocomposites: comparing released fragments and their in-vivo hazards from three release mechanisms and four nanocomposites. Small 7, 2384–95 (2011). 29. Pirela, S.V. et al. Effects of intratracheally instilled laser printer-emitted engineered nanoparticles in a mouse model: a case study of toxicological implications from nanomaterials released during consumer use. NanoImpact 1, 1–8 (2016). 30. Pirela, S.V et al. Consumer exposures to laser printer-emitted engineered nanoparticles: a case study of life-cycle implications from nano-enabled products. Nanotoxicology 9, 760–8 (2015). 31. Pirela, S. et al. Effects of copy center particles on the lungs: a toxicological characterization using a Balb/c mouse model. Inhal. Toxicol. 25, 498–508 (2013). 32. Demokritou, P. et al. An in vivo and in vitro toxicological characterisation of realistic nanoscale CeO2 inhalation exposures. Nanotoxicology 7, 1338–50 (2013). 33. Cohen, J., Deloid, G., Pyrgiotakis, G. & Demokritou, P. Interactions of engineered nanomaterials in physiological media and implications for in vitro dosimetry. Nanotoxicology 7, 417–31 (2013). 34. Gangwal, S. et al. Informing selection of nanomaterial concentrations for ToxCast in vitro testing based on occupational exposure potential. Environ. Health Perspect. 119, 1539–46 (2011). 35. Oberdörster, G. Nanotoxicology: in vitro-in vivo dosimetry. Environ. Health Perspect. 120, A13 author reply A13 (2012). 36. DeLoid, G. et al. Estimating the effective density of engineered nanomaterials for in vitro dosimetry. Nat. Commun. 5, 3514 (2014). 37. DeLoid, G.M. et al. Advanced computational modeling for in vitro nanomaterial dosimetry. Part. Fibre Toxicol. 12, 32 (2015). 38. Pal, A.K. et al. High resolution characterization of engineered nanomaterial dispersions in complex media using tunable resistive pulse sensing technology. ACS Nano 8, 9003–15 (2014). 39. Teeguarden, J.G., Hinderliter, P.M., Orr, G., Thrall, B.D. & Pounds, J.G. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 95, 300–12 (2007). 40. Bakand, S., Winder, C., Khalil, C. & Hayes, A. Toxicity assessment of industrial chemicals and airborne contaminants: transition from in vivo to in vitro test methods: a review. Inhal. Toxicol. 17, 775–87 (2005). 41. Pyrgiotakis, G., Blattmann, C.O. & Demokritou, P. Real-time nanoparticlecell interactions in physiological media by atomic force microscopy. ACS Sustain. Chem. Eng. 2, 1681–1690 (2014). 42. Pyrgiotakis, G., Blattmann, C.O., Pratsinis, S. & Demokritou, P. Nanoparticle-nanoparticle interactions in biological media by atomic force microscopy. Langmuir 29, 11385–95 (2013). 43. Lundqvist, M. et al. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 5, 7503–7509 (2011). 44. Buford, M.C., Hamilton, R.F. & Holian, A. A comparison of dispersing media for various engineered carbon nanoparticles. Part. Fibre Toxicol. 4, 6 (2007). 45. Sharma, G. et al. Iron oxide nanoparticle agglomeration influences dose rates and modulates oxidative stress-mediated dose-response profiles in vitro. Nanotoxicology 8, 663–75 (2014). Note: Any Supplementary Information and Source Data files are available in the online version of the paper. acknowleDGMents This research project was supported by a Harvard– National Institute of Environmental Health Sciences Nanosafety Center grant (1U24ES026946) and a National Science Foundation grant (1436450), both awarded to P.D. autHor contrIbutIons G.M.D., J.M.C., G.P., and P.D. co-wrote the manuscript. P.D. oversaw the manuscript preparation. coMpetInG FInancIal Interests The authors declare no competing financial interests. Reprints and permissions information is available online at http://www.nature. com/reprints/index.html. 1. Ma, X., Wang, Q., Rossi, L., Ebbs, S.D. & White, J.C. Multigenerational exposure to cerium oxide nanoparticles: physiological and biochemical analysis reveals transmissible changes in rapid cycling Brassica rapa. NanoImpact 1, 46–54 (2016). 2. Pyrgiotakis, G. et al. A chemical free, nanotechnology-based method for airborne bacterial inactivation using engineered water nanostructures. Environ. Sci. Nano 1, 15–26 (2014). 3. Pyrgiotakis, G. et al. Mycobacteria inactivation using engineered water nanostructures (EWNS). Nanomedicine 10, 1175–83 (2014). 4. Pyrgiotakis, G. et al. Inactivation of foodborne microorganisms using engineered water nanostructures (EWNS). Environ. Sci. Technol. 49, 3737–45 (2015). 5. Pyrgiotakis, G. et al. Optimization of a nanotechnology based antimicrobial platform for food safety applications using engineered water nanostructures (EWNS). Sci. Rep. 6, 21073 (2016). 6. Roco, M.C., Mirkin, C.A. & Hersan, M.C. Nanotechnology Research Directions for Societal Needs in 2020, Retrospective and Outlook (Springer, 2011). 7. Servin, A.D. & White, J.C. Nanotechnology in agriculture: next steps for understanding engineered nanoparticle exposure and risk. NanoImpact 1, 9–12 (2016). 8. Sotiriou, G.A. et al. Engineering safer-by-design, transparent, silica-coated ZnO nanorods with reduced DNA damage potential. Environ. Sci. Nano 1, 144–153 (2014). 9. Bott, J., Störmer, A. & Franz, R. A model study into the migration potential of nanoparticles from plastics nanocomposites for food contact. Food Packag. Shelf Life 2, 73–80 (2014). 10. Froggett, S.J., Clancy, S.F., Boverhof, D.R. & Canady, R.A. A review and perspective of existing research on the release of nanomaterials from solid nanocomposites. Part. Fibre Toxicol. 11, 17 (2014). 11. Grassian, V.H. et al. NanoEHS – defining fundamental science needs: no easy feat when the simple itself is complex. Environ. Sci. Nano 3, 15–27 (2016). 12. Konduru, N.V et al. Silica coating influences the corona and biokinetics of cerium oxide nanoparticles. Part. Fibre Toxicol. 12, 31 (2015). 13. Lu, X. et al. In vivo epigenetic effects induced by engineered nanomaterials: a case study of copper oxide and laser printer-emitted engineered nanoparticles. Nanotoxicology 10, 629–39 (2016). 14. Pal, A.K. et al. Linking exposures of particles released from nano-enabled products to toxicology: an integrated methodology for particle sampling, extraction, dispersion, and dosing. Toxicol. Sci. 146, 321–33 (2015). 15. Watson, C. et al. High-throughput screening platform for engineered nanoparticle-mediated genotoxicity using CometChip technology. ACS Nano 8, 2118–33 (2014). 16. Yetisen, A.K. et al. Nanotechnology in textiles. ACS Nano 10, 3042–3068 (2016). 17. Zhou, E.H. et al. Assessing the impact of engineered nanoparticles on wound healing using a novel in vitro bioassay. Nanomedicine (Lond.) 9, 2803–15 (2014). 18. Balbus, J.M. et al. Meeting report: hazard assessment for nanoparticles-report from an interdisciplinary workshop. Environ. Health Perspect. 115, 1654–9 (2007). 19. George, S. et al. Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano 5, 1805–17 (2011). 20. Krewski, D. et al. Toxicity testing in the 21st century: a vision and a strategy. J. Toxicol. Environ. Health B Crit. Rev. 13, 51–138 (2010).\n© 20\n17 M\nac m\nill an\nP u\nb lis\nh er\ns L\nim it\ned , p\nar t\no f\nS p\nri n\ng er\nN at\nu re\n. A ll\nri g\nh ts\nr es\ner ve\nd .\nnature protocols | VOL.12 NO.2 | 2017 | 371\n46. Watson, C.Y., DeLoid, G.M., Pal, A. & Demokritou, P. Buoyant nanoparticles: implications for nano-biointeractions in cellular studies. Small 12, 3172–3180 (2016). 47. Cai, W. The optimized fabrication of nanobubbles as ultrasound contrast agents for tumor imaging. Sci. Rep. 5, 13725 (2015). 48. DasSarma, S. et al. An improved genetic system for bioengineering buoyant gas vesicle nanoparticles from Haloarchaea. BMC Biotechnol. 13, 112 (2013). 49. Schmit, V.L., Martoglio, R., Scott, B., Strickland, A.D. & Carron, K.T. Labon-a-bubble: synthesis, characterization, and evaluation of buoyant gold nanoparticle-coated silica spheres. J. Am. Chem. Soc. 134, 59–62 (2012). 50. Suzuki, R. & Maruyama, K. Effective in vitro and in vivo gene delivery by the combination of liposomal bubbles (bubble liposomes) and ultrasound exposure. Methods Mol. Biol. 605, 473–86 (2010). 51. Wittmaack, K. Excessive delivery of nanostructured matter to submersed cells caused by rapid gravitational settling. ACS Nano 5, 3766–3778 (2011). 52. Wittmaack, K. Novel dose metric for apparent cytotoxicity effects generated by in vitro cell exposure to silica nanoparticles. Chem. Res. Toxicol. 24, 150–158 (2011). 53. Pal, A.K., Bello, D., Cohen, J. & Demokritou, P. Implications of in vitro dosimetry on toxicological ranking of low aspect ratio engineered nanomaterials. Nanotoxicology 9, 871–885 (2015). 54. Cohen, J.M., Teeguarden, J.G. & Demokritou, P. An integrated approach for the in vitro dosimetry of engineered nanomaterials. Part. Fibre Toxicol. 11, 20 (2014). 55. Cohen, J.M. et al. Tracking translocation of industrially relevant engineered nanomaterials (ENMs) across alveolar epithelial monolayers in vitro. Nanotoxicology 8, 216–25 (2014). 56. Kreyling, W.G. et al. In vitro and in vivo interactions of selected nanoparticles with rodent serum proteins and their consequences in biokinetics. Beilstein J. Nanotechnol. 5, 1699–711 (2014). 57. Anjilvel, S. & Asgharian, B. A multiple-path model of particle deposition in the rat lung. Fundam. Appl. Toxicol. 28, 41–50 (1995). 58. Cassee, F.R. et al. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model. Arch. Toxicol. 76, 277–86 (2002). 59. Geraets, L., Oomen, A.G., Schroeter, J.D., Coleman, V.A. & Cassee, F.R. Tissue distribution of inhaled micro- and nano-sized cerium oxide particles in rats: results from a 28-day exposure study. Toxicol. Sci. 127, 463–73 (2012). 60. Pirela, S.V et al. Effects of laser printer-emitted engineered nanoparticles on cytotoxicity, chemokine expression, reactive oxygen species, DNA methylation, and DNA damage: a comprehensive in vitro analysis in human small airway epithelial cells, macrophages, and lymphoblasts. Environ. Health Perspect. 124, 210–219 (2016). 61. Powers, K.W., Palazuelos, M., Moudgil, B.M. & Roberts, S.M. Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology 1, 42–51 (2007). 62. Powers, K.W. et al. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol. Sci. 90, 296–303 (2006). 63. Brown, S.C. et al. Nanoparticle characterization for cancer nanotechnology and other biological applications. Methods Mol. Biol. 624, 39–65 (2010). 64. Brown, S.C. et al. Influence of shape, adhesion and simulated lung mechanics on amorphous silica nanoparticle toxicity. Adv. Powder Technol. 18, 69–79 (2007). 65. Crist, R.M. et al. Common pitfalls in nanotechnology: lessons learned from NCI’s Nanotechnology Characterization Laboratory. Integr. Biol. (Camb.) 5, 66–73 (2013). 66. Patri, A. et al. Nanotechnology characterization laboratory: a resource for translational research in nanomedicine. Abstr. Pap. Am. Chem. Soc. 238, COLL 101 (2008). 67. Warheit, D.B. & Donner, E.M. How meaningful are risk determinations in the absence of a complete dataset? Making the case for publishing standardized test guideline and ‘no effect’ studies for evaluating the\nsafety of nanoparticulates versus spurious ‘high effect’ results from single investigative studies. Sci. Technol. Adv. Mater. 16, 034603 (2015).\n68. Cohen, J.M., DeLoid, G.M. & Demokritou, P. A critical review of in vitro dosimetry for engineered nanomaterials. Nanomedicine (Lond.) 10, 3015–3032 (2015). 69. Schulze, C. et al. Not ready to use – overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology 2, 51–61 (2008). 70. Taurozzi, J.S., Hackley, V.A. & Weisner, M.W. Preparation of Nanoparticle Dispersions from Powdered Material Using Ultrasonic Disruption. NIST Special Publication 1200-2, 1–15 (2012) http://dx.doi.org/10.6028/NIST.SP.1200-2. 71. Taurozzi, J.S., Hackley, V.A. & Wiesner, M.R. Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment--issues and recommendations. Nanotoxicology 5, 711–29 (2011). 72. Taurozzi, J.S., Hackley, V.A. & Wiesner, M.R. A standardised approach for the dispersion of titanium dioxide nanoparticles in biological media. Nanotoxicology 7, 389–401 (2013). 73. Wu, W. et al. Dispersion method for safety research on manufactured nanomaterials. Ind. Health 52, 54–65 (2014). 74. Wohlleben, W. Validity range of centrifuges for the regulation of nanomaterials: from classification to as-tested coronas. J. Nanopart. Res. 14, 1300 (2012). 75. Sterling, M.C., Bonner, J.S., Ernest, A.N.S., Page, C.A. & Autenrieth, R.L. Application of fractal flocculation and vertical transport model to aquatic sol-sediment systems. Water Res. 39, 1818–30 (2005). 76. Carney, R.P. et al. Determination of nanoparticle size distribution together with density or molecular weight by 2D analytical ultracentrifugation. Nat. Commun. 2, 335 (2011). 77. Hinderliter, P.M. et al. ISDD: a computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part. Fibre Toxicol. 7, 36 (2010). 78. Ma, R. et al. Size-controlled dissolution of organic-coated silver nanoparticles. Environ. Sci. Technol. 46, 752–9 (2012). 79. Odzak, N., Kistler, D., Behra, R. & Sigg, L. Dissolution of metal and metal oxide nanoparticles in aqueous media. Environ. Pollut. 191, 132–8 (2014). 80. Kittler, S., Greulich, C., Diendorf, J., Ko¨ller, M. & Epple, M. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem. Mater. 22, 4548–4554 (2010). 81. Vasyukova, E., Pokrovsky, O.S., Viers, J. & Dupré, B. New operational method of testing colloid complexation with metals in natural waters. Appl. Geochem. 27, 1226–1237 (2012). 82. Lu, X. et al. Short-term exposure to engineered nanomaterials affects cellular epigenome. Nanotoxicology 10, 140–150 (2015). 83. Ayán-Varela, M. et al. Achieving extremely concentrated aqueous dispersions of graphene flakes and catalytically efficient graphene-metal nanoparticle hybrids with flavin mononucleotide as a high-performance stabilizer. ACS Appl. Mater. Interfaces 7, 10293–307 (2015). 84. Zhang, L. et al. Rationally designed surfactants for few-layered graphene exfoliation: ionic groups attached to electron-deficient π-conjugated unit through alkyl spacers. ACS Nano 8, 6663–70 (2014). 85. Vanhecke, D. et al. Quantification of nanoparticles at the single-cell level: an overview about state-of-the-art techniques and their limitations. Nanomedicine (Lond.) 9, 1885–900 (2014). 86. Demokritou, P. et al. Development and characterization of a Versatile Engineered Nanomaterial Generation System (VENGES) suitable for toxicological studies. Inhal. Toxicol. 22, 107–116 (2010). 87. Gass, S. et al. A safer formulation concept for flame-generated engineered nanomaterials. ACS Sustain. Chem. Eng. 1, 843–857 (2013). 88. Sotiriou, G.A. et al. Thermal decomposition of nano-enabled thermoplastics: possible environmental health and safety implications. J. Hazard. Mater. 305, 87–95 (2016). 89. Gauss, C.F. Besprechung des Buchs von L.A. Seeber: Untersuchungen über die Eigenschaften der positiven ternären quadratischen Formen usw. Göttingsche Gelehrt. Anzeigen 2, 188–196 (1831). 90. Song, C., Wang, P. & Makse, H.A. A phase diagram for jammed matter. Nature 453, 629–632 (2008)."
    } ],
    "references" : [ {
      "title" : "physiological and biochemical analysis reveals transmissible changes in rapid cycling Brassica rapa",
      "author" : [ "X. Ma", "Q. Wang", "L. Rossi", "S.D. Ebbs", "White", "J.C. Multigenerational exposure to cerium oxide nanoparticles" ],
      "venue" : "NanoImpact 1, 46–54",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "A chemical free, nanotechnology-based method for airborne bacterial inactivation using engineered water nanostructures",
      "author" : [ "G Pyrgiotakis" ],
      "venue" : "Environ. Sci. Nano 1,",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2014
    }, {
      "title" : "Mycobacteria inactivation using engineered water nanostructures (EWNS)",
      "author" : [ "G Pyrgiotakis" ],
      "venue" : "Nanomedicine 10,",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2014
    }, {
      "title" : "Inactivation of foodborne microorganisms using engineered water nanostructures (EWNS)",
      "author" : [ "G Pyrgiotakis" ],
      "venue" : "Environ. Sci. Technol",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2015
    }, {
      "title" : "Optimization of a nanotechnology based antimicrobial platform for food safety applications using engineered water nanostructures (EWNS)",
      "author" : [ "G Pyrgiotakis" ],
      "venue" : "Sci. Rep",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 2016
    }, {
      "title" : "Nanotechnology Research Directions for Societal Needs in 2020",
      "author" : [ "M.C. Roco", "C.A. Mirkin", "M.C. Hersan" ],
      "venue" : "Retrospective and Outlook (Springer,",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2011
    }, {
      "title" : "next steps for understanding engineered nanoparticle exposure and risk",
      "author" : [ "A.D. Servin", "White", "J.C. Nanotechnology in agriculture" ],
      "venue" : "NanoImpact 1, 9–12",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Engineering safer-by-design, transparent, silica-coated ZnO nanorods with reduced DNA damage potential",
      "author" : [ "Sotiriou", "G.A" ],
      "venue" : "Environ. Sci. Nano 1,",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2014
    }, {
      "title" : "A model study into the migration potential of nanoparticles from plastics nanocomposites for food contact",
      "author" : [ "J. Bott", "A. Störmer", "R. Franz" ],
      "venue" : "Food Packag. Shelf Life",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2014
    }, {
      "title" : "A review and perspective of existing research on the release of nanomaterials from solid nanocomposites",
      "author" : [ "S.J. Froggett", "S.F. Clancy", "D.R. Boverhof", "R.A. Canady" ],
      "venue" : "Part. Fibre Toxicol. 11,",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2014
    }, {
      "title" : "no easy feat when the simple itself is complex",
      "author" : [ "Grassian", "V.H. et al. NanoEHS – defining fundamental science needs" ],
      "venue" : "Environ. Sci. Nano 3, 15–27",
      "citeRegEx" : "11",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Silica coating influences the corona and biokinetics of cerium oxide nanoparticles",
      "author" : [ "Konduru", "N.V" ],
      "venue" : "Part. Fibre Toxicol. 12,",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2015
    }, {
      "title" : "a case study of copper oxide and laser printer-emitted engineered nanoparticles",
      "author" : [ "Lu", "X. et al. In vivo epigenetic effects induced by engineered nanomaterials" ],
      "venue" : "Nanotoxicology 10, 629–39",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "an integrated methodology for particle sampling, extraction, dispersion, and dosing",
      "author" : [ "Pal", "A.K. et al. Linking exposures of particles released from nano-enabled products to toxicology" ],
      "venue" : "Toxicol. Sci. 146, 321–33",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "High-throughput screening platform for engineered nanoparticle-mediated genotoxicity using CometChip technology",
      "author" : [ "C Watson" ],
      "venue" : "ACS Nano 8,",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2014
    }, {
      "title" : "Nanotechnology in textiles",
      "author" : [ "Yetisen", "A.K" ],
      "venue" : "ACS Nano 10,",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2016
    }, {
      "title" : "Assessing the impact of engineered nanoparticles on wound healing using a novel in vitro bioassay",
      "author" : [ "Zhou", "E.H" ],
      "venue" : "Nanomedicine (Lond.)",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2014
    }, {
      "title" : "hazard assessment for nanoparticles-report from an interdisciplinary workshop",
      "author" : [ "Balbus", "J.M. et al. Meeting report" ],
      "venue" : "Environ. Health Perspect. 115, 1654–9",
      "citeRegEx" : "18",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials",
      "author" : [ "S George" ],
      "venue" : "ACS Nano 5,",
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2011
    } ],
    "referenceMentions" : [ ],
    "year" : 2017,
    "abstractText" : "nature protocols | VOL.12 NO.2 | 2017 | 355 IntroDuctIon The unique physicochemical properties of ENMs are being exploited for use in a growing variety of commercial nano-enabled products (NEPs), including electronics, cosmetics, and structural materials, as well as a wide variety of products for antimicrobial, agricultural, medical, therapeutic, and diagnostic applications1–8. The rapid proliferation and commercialization of these ENMs and associated NEPs poses a potential risk of both occupational and consumer exposures to materials for which toxicological data are extremely limited9–17. Moreover, the high degree of variability in physicochemical properties such as composition, size, morphology, surface topology, chemistry and modifications, crystallinity, and impurity content among these ENMs presents a substantial challenge to the nanotoxicology field18–22. In addition, human exposure is not limited to pristine ENMs but also includes a wide variety of particles released from NEPs across their life cycle, including at the consumer use and disposal stages6,23,24. Indeed, the potential for exposure from such life cycle particulate matter (LCPM) may exceed that of pristine ENMs23. To complicate the matter further, the physicochemical properties and toxicological profiles of LCPM may differ greatly from those of the corresponding pristine ENMs14,25–31. To address the vast and growing number and variety of ENMs entering the market, there is great need for fast, inexpensive, and in vivo-validated high-throughput screening strategies based on in vitro cellular assays. However, in vitro testing results from different labs often contradict one another, and even greater disparity is observed between in vitro and in vivo results19,20,32. Much of this in vitro vs. in vivo disparity can be explained by the failure of simple cellular systems (which often use immortal, i.e., highly abnormal, cell lines) to adequately recapitulate the complex milieu of a mammalian organism. However, it is likely that mismatch of in vitro and in vivo doses, due to inadequate ENM characterization—and particularly failure to adequately account for fate and transport of ENMs in vitro—is a major contributor to these disparities33–38.",
    "creator" : "Adobe InDesign CS2 (4.0)"
  }
}